Gene · 92521
NIH grants1,071
NIH grants whose papers are about the gene, through NIH's grant-paper links.
801 to 820 of 1,071
Download this page as JSON| Grant | Title | SPECC1 papers | Newest fiscal year |
|---|---|---|---|
| R01HL119485 | Novel viruses and viral dynamics in multiple transfusion recipients | 1 | 2018 |
| R01HL128172 | Epigenenomic and transcriptomic networks in normal and defective lung development | 1 | 2018 |
| R03AI131072 | Genetic Engineering of the rotavirus genome through a fully recombinant reverse gene | 1 | 2018 |
| R21AI129369 | Rapid Phenotyping of the ZIKV Genome | 1 | 2018 |
| R21AI133219 | In vivo efficacy studies of existing drugs re-purposed for flaviviruses in mouse models | 1 | 2018 |
| R21AI134568 | New Use of Old Drugs for Zika Virus | 1 | 2018 |
| R37AI027690 | HIV-1 reverse transcriptase structure: function, inhibition, and resistance | 1 | 2018 |
| R37HL060917 | Nitric Oxide in Pulmonary Hypertension | 1 | 2018 |
| R41AI132047 | Therapeutic antibodies for treatment of hantavirus cardiopulmonary syndrome | 1 | 2018 |
| R56AI138613 | Chemical, Nanomedicine and Autophagy Strategies to Create Sustained-Release Antiretroviral Products | 1 | 2018 |
| S10OD023555 | MANTA ViewSizer 3011 Nanoparticle Characterization System | 1 | 2018 |
| T32AI078985 | Virology Training Grant | 1 | 2018 |
| T32DK007632 | Basic Science Research in Digestive Diseases | 1 | 2018 |
| U01CA207160 | Drug Repurposing for Cancer Therapy: From Man to Molecules to Man | 1 | 2018 |
| U01HL122700 | Biorepository for Investigation of Neonatal Diseases of Lung-Normal (BRINDL-NL) | 1 | 2018 |
| U01HL126494 | Reference Profiles of ExRNAs in Normal Human Pregnancy | 1 | 2018 |
| U19AI109945 | Mechanisms of evasion of the innate and adaptive immune responses to filoviruses | 1 | 2018 |
| U19AI109962 | Virus-induced Cell Fate Decisions in Anti-Viral Immunity | 1 | 2018 |
| R01AI045000 | Defining the cis and trans acting factors required for assembly of infectious Blu | 3 | 2017 |
| U41HG006673 | Systematic Exploration of the Human Interactome | 3 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/grants?page=41